Faloon Patrick, Jewett Ivan, Youngsaye Willmen, Bennion Melissa, Ng Wai-Leung, Hurley Amanda, Lewis Timothy A., Edwankar Rahul V., Le Hanh, Mosher Carrie M., Johnston Stephen, Dandapani Sivaraman, Munoz Benito, Palmer Michelle, Bassler Bonnie L., Schreiber Stuart L.
The Broad Institute Probe Development Center, Cambridge, MA
Princeton University, Princeton, NJ
Quorum sensing (QS) is a process of bacterial cell-to-cell communication that relies upon recognition of extracellular signaling molecules called autoinducers. QS allows bacteria to synchronize their behavior in response to changes in the population density and species composition of the proximal bacterial community. Known behaviors regulated by QS include bioluminescence, sporulation, virulence factor production, and biofilm formation. We carried out a high throughput screen (HTS) to identify small molecules that modulate QS in a modified strain carrying a luciferase operon; activation of the quorum pathway is accompanied by light production. 352,083 compounds from the National Institutes of Health Molecular Libraries Probe Production Centers Network (NIH-MLPCN) compound library were evaluated. Potential QS modulators were characterized additional bacterial epistatic assays to elucidate the mode of action. We report the discovery and development of a substituted 2-amino-oxadiazole (ML366) as an inhibitor of LuxO, a response regulator and intracellular kinase. ML366 acts directly on LuxO by inhibiting ATPase activity. ML366 should greatly expand the general understanding of how QS response regulators relay information from upstream signals that lead to modified gene expression. In addition, these compounds could lead to the development of antibacterial drugs designed to interfere with QS which could have enormous ramifications for improving human health.
